Binding Sites on Spike Protein and Cysteine Protease Mpro of Covid-19 and Identification of New Molecules Designed from Scaffolds and Pharmacophores of Phytochemicals and Synthetic Molecules that can act as Antivirals for Treatment of Covid-19

The Coronavirus outbreak came to light on December 31, 2019 when China informed the World Health Organization. The growing COVID-19 global health crisis led us to contribute in scientific community. Kcat has contributed in identifying (Patent No: 202041038649, 08th Sep-20) antiviral compounds that can modulate the Cysteine protease Mpro and Spike protein of covid-19.